Marksans Pharma Q4 Results Live : profit falls by 4.44% YOY

Marksans Pharma Q4 Results Live : Revenue increased by 15.23% YoY & profit decreased by 4.44% YoY

First Published2 Jun 2024

Marksans Pharma Q4 Results Live : Marksans Pharma declared their Q4 results on 30 May, 2024. The topline increased by 15.23% & the profit decreased by 4.44% YoY. Compared to the previous quarter, the revenue declined by 4.46% and the profit decreased by 5.94%.

The Selling, general & administrative expenses rose by 7.01% q-o-q and increased by 30.97% Y-o-Y.

The operating income was down by 20.21% q-o-q and decreased by 7.34% Y-o-Y.

The EPS is ₹1.73 for Q4 which decreased by 6.4% Y-o-Y.

Marksans Pharma has delivered -13.31% return in the last 1 week, -11.9% return in the last 6 months, and -9.03% YTD return.

Currently, Marksans Pharma has a market cap of ₹6641.11 Cr and 52wk high/low of ₹185.5 & ₹82.1 respectively.

Marksans Pharma Financials

Period	Q4	Q3	Q-o-Q Growth	Q4	Y-o-Y Growth
Total Revenue	560.01	586.13	-4.46%	485.98	+15.23%
Selling/ General/ Admin Expenses Total	79.75	74.53	+7.01%	60.89	+30.97%
Depreciation/ Amortization	21.05	22	-4.31%	13.94	+51%
Total Operating Expense	471.43	475.11	-0.77%	390.37	+20.76%
Operating Income	88.59	111.02	-20.21%	95.6	-7.34%
Net Income Before Taxes	100.28	112.66	-10.99%	104.17	-3.74%
Net Income	78.29	83.23	-5.94%	81.93	-4.44%
Diluted Normalized EPS	1.73	1.84	-5.98%	1.85	-6.4%